WallStreetZenWallStreetZen

NASDAQ: ATXS
Astria Therapeutics Inc Stock Ownership - Who owns Astria Therapeutics?

Insider buying vs selling

Have Astria Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Christopher MorabitoChief Medical Officer2024-04-0110,000$13.59
$135.94kSell
Christopher MorabitoChief Medical Officer2024-04-0110,000$3.87
$38.70kBuy
Perceptive Advisors LLCDirector2024-02-012,481,350$12.09
$30.00MBuy
Christopher MorabitoChief Medical Officer2024-01-299,200$3.87
$35.60kBuy
Christopher MorabitoChief Medical Officer2024-01-299,200$11.15
$102.55kSell
Christopher MorabitoChief Medical Officer2024-01-26800$11.02
$8.81kSell
Christopher MorabitoChief Medical Officer2024-01-26800$3.87
$3.10kBuy
Perceptive Advisors LLCDirector2023-12-21740,000$6.20
$4.59MBuy
Perceptive Advisors LLCDirector2023-10-16460,546$6.51
$3.00MBuy
Perceptive Advisors LLCDirector2023-10-16614,062$6.51
$4.00MBuy

1 of 1

ATXS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATXS insiders and whales buy or sell their stock.

ATXS Shareholders

What type of owners hold Astria Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC11.81%6,485,420$61.16MInstitution
Tcg Crossover Management LLC9.61%5,278,928$49.78MInstitution
Ra Capital Management LP8.04%4,413,150$41.62MInstitution
Fmr LLC7.87%4,319,157$40.73MInstitution
Vr Adviser LLC6.57%3,608,645$34.03MInstitution
Blackrock Inc6.53%3,585,493$33.81MInstitution
Fairmount Funds Management LLC6.47%3,554,129$33.52MInstitution
Nicholas Galakatos5.01%2,752,488$25.96MInsider
Clarus Lifesciences Ii LP5.01%2,752,488$25.96MInsider
Vanguard Group Inc4.62%2,535,891$23.91MInstitution

1 of 3

ATXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATXS80.70%19.30%Net BuyingNet Buying
YMAB52.43%39.22%Net BuyingNet Selling
ALLO62.22%37.78%Net SellingNet Selling
ANL0.05%0.00%
OCGN12.76%11.93%Net Selling

Astria Therapeutics Stock Ownership FAQ

Who owns Astria Therapeutics?

Astria Therapeutics (NASDAQ: ATXS) is owned by 104.89% institutional shareholders, 25.09% Astria Therapeutics insiders, and 0.00% retail investors. Nicholas Galakatos is the largest individual Astria Therapeutics shareholder, owning 2.75M shares representing 5.01% of the company. Nicholas Galakatos's Astria Therapeutics shares are currently valued at $25.96M.

If you're new to stock investing, here's how to buy Astria Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.